VTE is a major cause of morbidity and mortality in hospitals. Pharmacologic prophylaxis has been shown to reduce the risk of clinically significant VTE. Although VTE prevention should be considered for every hospitalized patient, excess VTE prophylaxis—either prophylaxis inappropriately administered to patients at low risk of VTE or to high-risk patients with contraindications—can be harmful. National guidelines recommend objective risk stratification for VTE prevention in hospitalized medical patients.